Investigational Drug Information for Bufotenin
✉ Email this page to a colleague
What is the development status for investigational drug Bufotenin?
Bufotenin is an investigational drug.
There have been 5 clinical trials for Bufotenin.
The most recent clinical trial was a Phase 1 trial, which was initiated on March 7th 2023.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Depressive Disorder, Treatment-Resistant. The leading clinical trial sponsors are GH Research Ireland Limited and [disabled in preview].
There are eighty-six US patents protecting this investigational drug and four hundred and ninety-six international patents.
Summary for Bufotenin
US Patents | 86 |
International Patents | 496 |
US Patent Applications | 424 |
WIPO Patent Applications | 285 |
Japanese Patent Applications | 115 |
Clinical Trial Progress | Phase 1 (2023-03-07) |
Vendors | 31 |
Recent Clinical Trials for Bufotenin
Title | Sponsor | Phase |
---|---|---|
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder | GH Research Ireland Limited | Phase 2 |
A Trial of GH001 in Patients With Treatment-resistant Depression | GH Research Ireland Limited | Phase 2 |
Phase 2 Clinical Trial of GH001 in Postpartum Depression | GH Research Ireland Limited | Phase 2 |
Clinical Trial Summary for Bufotenin
Top disease conditions for Bufotenin
Top clinical trial sponsors for Bufotenin
US Patents for Bufotenin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Bufotenin | ⤷ Try a Trial | Pharmaceutical compositions resistant to abuse | EGALET LTD. (London, GB) | ⤷ Try a Trial |
Bufotenin | ⤷ Try a Trial | Abuse-deterrent controlled release formulations | Patheon Softgels Inc. (High Point, NC) | ⤷ Try a Trial |
Bufotenin | ⤷ Try a Trial | Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features | Pisgah Laboratories, Inc. (Pisgah Forest, NC) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bufotenin
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Bufotenin | Australia | AU2010211376 | 2029-02-06 | ⤷ Try a Trial |
Bufotenin | Australia | AU2013257533 | 2029-02-06 | ⤷ Try a Trial |
Bufotenin | Canada | CA2751627 | 2029-02-06 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |